Table 2 Clinical data from hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) patients enrolled in this study. Number of patients and frequencies (%) are indicated
CCA N = 8 | HCC N = 20 | ||
|---|---|---|---|
TNM | Stage I | 1 (13%) | 3 (15%) |
Stage II | 4 (50%) | 15 (75%) | |
Stage IIIA | 0 (0%) | 1 (5%) | |
Stage IV | 3 (38%) | 1 (5%) | |
Histologic grade (G) | G1 | 2 (25%) | 2 (10%) |
G2 | 3 (38%) | 11 (55%) | |
G3 | 3 (38%) | 6 (30%) | |
G4 | 0 (0%) | 1 (5%) | |
HBsAg | Positive | 0 (0%) | 1 (5%) |
HCV | Positive | 0 (0%) | 6 (30%) |
Vascular microinvasion | Positive | – | 8 (40%) |
Cirrhosis | 0 (0%) | 15 (75%) | |
Relapse | 3 (38%) | 1 (5%) | |
Death | 3 (38%) | 2 (10%) | |
Liver Transplant | 0 (0%) | 7 (35%) | |